Tag Archives: Healthcare

Medicare is almost $200 billion in gross drug spend: Who gets the blame? — 46brooklyn Research This is a complex issue as there are many moving parts to drug pricing and their costs. Perplexing in describing the drug spend issues would seem appropriate. I am not even sure if this long post will adequately define the issue of how drug prices are set. However, here is another article which I believe may break this down even more so. Later on...

How can that be? Something the Biden administration did made access to Medicare easier by providing quicker access to Medicare. The Medicare improvements incorporate no delay in coverage, better access (SEPS), and eliminates late enrollment penalties for Part B under certain conditions. According to CNN news and other news outlets, Biden has taken credit for things he did not do. Rather than mistakes made in announcing economic improvements,...

A lot of good and assorted News topics to be read. I did not include any about the upcoming election. I did include one on polling. The same as 2020, I believe the polling results are tainted. We are not getting a clear picture from polling or news reporting. That is just one of 30-something articles and links here this week. Heavy on healthcare. and the Economy, otherwise an eclectic mix of assorted news topics. Politics “Only the GOP...

I think I have this initial chart big enough so you can see it. I should not have to explain this as it is apparent what is happening with ACA (PPACA) healthcare insurance. The pricing decrease and stability shown is due to Joe Biden’s ARPA enhancing subsidies. The ARPA lower cost results are also increasing enrollment 21% from last year. The premiums will remain in place for three-years. And this too is inflationary as everyone spends money to...

October 25, 2022, Heather Cox Richardson, (substack.com). There are quotes, and then there are quotes. Tonight, in the debate between Democratic candidate John Fetterman and Republican candidate Mehmet Oz as part of their campaigns to replace Republican Pennsylvania senator Pat Toomey, who is retiring, Oz said he wanted abortion decisions to be made by “women, doctors, local political leaders, letting the democracy that’s always allowed our...

Quite a few varying articles in healthcare and other topics this week. Pfizer is hoping to make a killing on it mRNA vaccine, shots are approved for 6 months to five-years of age, Medicare Advantage plans, and Novartis is back again with a cancer drug. A COA has blocked student loan relief, lots of talk about housing being blown-up, etc. Is business struggling over the last two years? Read about GM’s spectacular 3rd qtr, 2022. The bottom 50% of...

November 1st is the start of the official 2023 ACA Open Enrollment Period (OEP) for anyone who needs quality, affordable healthcare coverage. Charles Gaba at ACA Signups has a very detailed rundown on what is happening this year. Because of President Biden, there have been improvements to the ACA. What I have done below is a brief rundown of Charles Gaba’s Open Enrollment post. It is not as detailed as his post. If you are serious about using the...

This article by Charles Gaba is a long one. I did some editing on it to shorten it somewhat. The article covers the ACA “family glitch.” What has been occurring over the last 12 years is an IRS interpretation of the ACA language content. Family was not included in ACA’s premium subsidy coverage if an employee could pay for him or herself less than 9.78% of household income in 2020. In which case, the cost of dependents together or as individuals...

Much of this post is from “Among Seniors, a Declining Interest in Boosters,” (dnyuz.com). This article first appeared in the New York Times as authored by Paula Span, October 22, 2022. I think what is important here is the growing indifference to Covid. They have been inoculated against Covid with the original series of shots. Most went ahead with the two boosters to strengthen the original. Now with the third booster, they are displaying hesitance....

Coronavirus dashboard for October 21: the autumn lull continues, despite new subvariants  – by New Deal democrat No economic data today, so let’s update the status of COVID-19. We are currently in a relative lull, with confirmed cases, hospitalizations, and deaths all near or at low levels only matched or exceeded at mid-year 2021 and early spring of this year. Here is the 6 month view of confirmed cases and deaths: At the moment...